Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...

The agency has set a Prescription Drug User Fee Act (PDUFA ... along with reducing visits to hospital or infusion sites. The subcutaneous autoinjector dosing, which would also take far less time than ...

The agency has set a Prescription Drug User Fee Act ... along with reducing visits to hospital or infusion sites. The subcutaneous autoinjector dosing, which would also take far less time than ...

Continuous Subcutaneous Infusion of Foscarbidopa and Foslevodopa (Vyalev) The Vyalev system involves continuous subcutaneous infusion of foscarbidopa and foslevodopa. Unlike traditional oral ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

The FDA has started its review of a subcutaneous injection formulation ... rather than in an infusion clinic. Eisai and Biogen's filing is for a once-weekly autoinjector formulation of Leqembi ...

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to ...